The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

I make it my mission to shield every inch of my exposed, vulnerable, high-risk skin, including hands, forearms, chest, neck, and knees. Yeah, people mock me. But we’ll see who’s laughing when my knees ...

A new study from Indiana University scientists may aid the pharmaceutical industry in better understanding a popular over-the ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...